150 related articles for article (PubMed ID: 20036606)
61. Cytoplasmic neuropilin 2 is associated with metastasis and a poor prognosis in early tongue cancer patients.
Ong HS; Gokavarapu S; Xu Q; Tian Z; Li J; Ji T; Zhang CP
Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1205-1219. PubMed ID: 28602571
[TBL] [Abstract][Full Text] [Related]
62. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody.
Pytowski B; Goldman J; Persaud K; Wu Y; Witte L; Hicklin DJ; Skobe M; Boardman KC; Swartz MA
J Natl Cancer Inst; 2005 Jan; 97(1):14-21. PubMed ID: 15632376
[TBL] [Abstract][Full Text] [Related]
63. Simultaneous expression of furin and vascular endothelial growth factor in human oral tongue squamous cell carcinoma progression.
López de Cicco R; Watson JC; Bassi DE; Litwin S; Klein-Szanto AJ
Clin Cancer Res; 2004 Jul; 10(13):4480-8. PubMed ID: 15240540
[TBL] [Abstract][Full Text] [Related]
64. [Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer].
Chen YN; Gu Y
Ai Zheng; 2009 Dec; 28(12):1337-43. PubMed ID: 19958632
[TBL] [Abstract][Full Text] [Related]
65. The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C.
Moussai D; Mitsui H; Pettersen JS; Pierson KC; Shah KR; Suárez-Fariñas M; Cardinale IR; Bluth MJ; Krueger JG; Carucci JA
J Invest Dermatol; 2011 Jan; 131(1):229-36. PubMed ID: 20827282
[TBL] [Abstract][Full Text] [Related]
66. [Interleukin 7 and its receptor promote cell proliferation and induce lymphangiogenesis in non-small cell lung cancer].
Ming J; Zhang QF; Jiang YD; Jiang GC; Qiu XS
Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):511-8. PubMed ID: 23157741
[TBL] [Abstract][Full Text] [Related]
67. Hyperthermia inhibited the migration of tongue squamous cell carcinoma through TWIST2.
Tang YL; Jiang J; Liu J; Zheng M; He YW; Chen W; Fan YL; Chen QM; Liao CH; Liang XH
J Oral Pathol Med; 2015 May; 44(5):337-44. PubMed ID: 25048179
[TBL] [Abstract][Full Text] [Related]
68. Experimental study of antiangiogenic gene therapy targeting VEGF in oral cancer.
Okada Y; Ueno H; Katagiri M; Oneyama T; Shimomura K; Sakurai S; Mataga I; Moride M; Hasegawa H
Odontology; 2010 Feb; 98(1):52-9. PubMed ID: 20155508
[TBL] [Abstract][Full Text] [Related]
69. The interplay of matrix metalloproteinase-8, transforming growth factor-β1 and vascular endothelial growth factor-C cooperatively contributes to the aggressiveness of oral tongue squamous cell carcinoma.
Åström P; Juurikka K; Hadler-Olsen ES; Svineng G; Cervigne NK; Coletta RD; Risteli J; Kauppila JH; Skarp S; Kuttner S; Oteiza A; Sutinen M; Salo T
Br J Cancer; 2017 Sep; 117(7):1007-1016. PubMed ID: 28772283
[TBL] [Abstract][Full Text] [Related]
70. Recombinant canstatin inhibits VEGF-A-induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC-VII animal model.
Hwang-Bo J; Park JH; Bae MG; Chung IS
Cancer Med; 2016 Oct; 5(10):2977-2988. PubMed ID: 27650585
[TBL] [Abstract][Full Text] [Related]
71. CCL5 promotes VEGF-C production and induces lymphangiogenesis by suppressing miR-507 in human chondrosarcoma cells.
Wang LH; Lin CY; Liu SC; Liu GT; Chen YL; Chen JJ; Chan CH; Lin TY; Chen CK; Xu GH; Chen SS; Tang CH; Wang SW
Oncotarget; 2016 Jun; 7(24):36896-36908. PubMed ID: 27166194
[TBL] [Abstract][Full Text] [Related]
72. VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma.
Du LC; Chen XC; Wang D; Wen YJ; Wang CT; Wang XM; Kan B; Wei YQ; Zhao X
Reprod Biol Endocrinol; 2014 Feb; 12():14. PubMed ID: 24502459
[TBL] [Abstract][Full Text] [Related]
73. Elevated VEGF-D Modulates Tumor Inflammation and Reduces the Growth of Carcinogen-Induced Skin Tumors.
Honkanen HK; Izzi V; Petäistö T; Holopainen T; Harjunen V; Pihlajaniemi T; Alitalo K; Heljasvaara R
Neoplasia; 2016 Jul; 18(7):436-46. PubMed ID: 27435926
[TBL] [Abstract][Full Text] [Related]
74. Anti-lymphangiogenesis effects of a specific anti-interleukin 7 receptor antibody in lung cancer model in vivo.
Jian M; Qingfu Z; Yanduo J; Guocheng J; Xueshan Q
Mol Carcinog; 2015 Feb; 54(2):148-55. PubMed ID: 24115038
[TBL] [Abstract][Full Text] [Related]
75. Correlation between CCR7 expression and lymph node metastatic potential of human tongue carcinoma.
Xia X; Liu K; Zhang H; Shang Z
Oral Dis; 2015 Jan; 21(1):123-31. PubMed ID: 24528991
[TBL] [Abstract][Full Text] [Related]
76. Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-D.
Kashima K; Watanabe M; Satoh Y; Hata J; Ishii N; Aoki Y
Cancer Sci; 2012 Dec; 103(12):2144-52. PubMed ID: 22937829
[TBL] [Abstract][Full Text] [Related]
77. Heterogeneous tumor stromal microenvironments of oral squamous cell carcinoma cells in tongue and nodal metastatic lesions in a xenograft mouse model.
Shirako Y; Taya Y; Sato K; Chiba T; Imai K; Shimazu Y; Aoba T; Soeno Y
J Oral Pathol Med; 2015 Oct; 44(9):656-68. PubMed ID: 25765182
[TBL] [Abstract][Full Text] [Related]
78. Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease.
Lee HS; Hos D; Blanco T; Bock F; Reyes NJ; Mathew R; Cursiefen C; Dana R; Saban DR
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3140-8. PubMed ID: 26024097
[TBL] [Abstract][Full Text] [Related]
79. [Effects of lactoferrin on vascular endothelial growth factor and basic fibroblast growth factor expression in human Tca8113 cell line].
Wang L; Wei XF; Sun HC
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Jan; 45(1):28-30. PubMed ID: 20368037
[TBL] [Abstract][Full Text] [Related]
80. Immunohistochemical predictors in squamous cell carcinoma of the tongue and floor of the mouth.
Gontarz M; Wyszyńska-Pawelec G; Zapała J; Czopek J; Lazar A; Tomaszewska R
Head Neck; 2016 Apr; 38 Suppl 1():E747-53. PubMed ID: 25900716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
